BRENDA ADEOGUN: Open Payments
NPI 1518445576 · TOMS RIVER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 34 payments from 8 companies in 2025. Trend: 2023 $461 · 2024 $313 · 2025 $655
Food & beverage: $655
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 8 | $164 |
| Teva Pharmaceuticals USA, Inc. | 10 | $154 |
| Neurocrine BioSciences, Inc. | 6 | $130 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $80 |
| Alkermes, Inc. | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
Products named: UZEDY, INGREZZA, INVEGA SUSTENNA, CAPLYTA, SPRAVATO, ARISTADA, LYBALVI, COBENFY.
Industry payments across NJ — which companies pay providers there.
